These findings strongly suggest that α3(IV)NC1 has the ability to inhibit pro-inflammatory factor COX-2, and inhibit tumor vasculature and tumor growth in an α3β1 integrin dependent manner (Boosani et al. 2007). Here, PTGS2 is linked to neoplasm.